Loading clinical trials...
Loading clinical trials...
This study is conducted in Europe. The aim of the study is to describe the patient population and therapeutic practices (study phase I), assess efficacy on growth and adult height and assess tolerance...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT07309562 · Small for Gestational Age
NCT02769975 · Adrenal Insufficiency, Growth Disorder, and more
NCT06723392 · Preterm Birth, Small for Gestational Age (SGA), and more
NCT06957769 · Low Birth Weight Baby, Small for Gestational Age (SGA), and more
NCT06918236 · Fetal Growth Restriction (FGR), Preeclampsia, and more
Novo Nordisk Investigational Site
Paris La Défense
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions